Menu Close

Stoke Therapeutics Presents Data Showing Single Dose of ASO Therapy Restores Normal Protein Levels in Animal Model of Genetic Epilepsy

Stoke’s ASO therapy is designed to raise the protein to normal levels. “These data are particularly exciting because this approach could lead to the first disease-modifying treatment for patients with Dravet Syndrome. Stoke is also working on applying … (본문 전체 12/2/2018 8:49 PM)